Effect of limited proteolysis on the stability and enzymatic activity of human placental S-adenosylhomocysteine hydrolase

Protein Science

Volumn 6, Issue 7, 1997, Pages 1482-1490

  Huang, He ^a   Yuan, Chong Sheng ^a   Borchardt, Ronald T ^a,b  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

CD; Limited proteolysis; Protein stability; S adenosylhomocysteine hydrolase; Tryptophan fluorescence

Indexed keywords

ADENOSYLHOMOCYSTEINASE; GUANIDINE; TRYPTOPHAN;

ARTICLE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME DEGRADATION; ENZYME STABILITY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN TISSUE; PLACENTA; PRIORITY JOURNAL; PROTEIN FOLDING; THERMOSTABILITY;

EID: 0030835792     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1002/pro.5560060712     Document Type: Article

References (33)

1. Aksamit RR, Backlund PS Jr, Moos M Jr, Caryk T, Gomi T, Ogawa H, Fujioka M, Cantoni GL. 1994. The role of cysteine 78 in fluorosulfonylbenzoyladenosine inactivation of rat liver S-adenosylhomocysteine hydrolase. J Biol Chem 269:4084-4091.
2. Ault-Riche DB, Yuan CS, Borchardt RT. 1994. A single mutation at lysine 426 of human placental S-adenosylhomocysteine hydrolase inactivates the enzyme. J Biol Chem 269:31472-31478.
3. Borcherding DR, Narayanan S, Hasobe M, McKee JG, Keller BT, Borchardt RT. 1988. Potential inhibitors of S-adenosylmethionine-dependent methyltransferase I. Molecular dissections of neplanocin A as potential inhibitors of S-adenosylhomocysteine hydrolase. J Med Chem 31:1729-1738.
4. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248-252.
5. Coulter-Karis DE, Hershfield MJ. 1989. Sequence of full length cDNA for human S-adenosylhomocysteine hydrolase. Annals Human Genetic 53:169-175.
6. DeClercq E. 1987. S-Adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agents. Biochem Pharmacol 36:2567-2575.
7. Gekko K, Yamagamik K, Kunori Y, Ichihara S, Kodana M, Iwakura M. 1993. Effects of point mutation in a flexible loop on the stability and enzymatic function of E. coli dihydrofolate reductase. J Biochem 113:74-80.
8. Gomi T, Fujioka M. 1983. Evidence from an essential histidine residue in S-adenosylhomocysteine from rat liver. Biochemistry 22:137-143.
9. Gomi T, Ogawa H, Fujioka M. 1986. S-adenosylhomocysteinase from rat liver: Amino acid sequences of the peptides containing active site cysteine residues modified by treatment with 5′-[p-(fluorosulfonyl benzoyl]adenosine. J Biol Chem 26:13427-13425.
10. Greene RF, Pace CN. 1974. Urea and guanidine hydrochloride denaturation of ribonuclease, lysozyme, alpha-chymotrypsin, and beta-lactoglobulin. J Biol Chem 249:5388-5393.
11. Gupta RA, Yuan CS, Ault-Riché DB, Borchardt RT. 1995. Limited proteolysis of S-adenosylhomocysteine hydrolase: Implication for the three-dimensional structure. Arch Biochem Biophys 319:365-371.
12. Hasobe M, McKee JG, Borchardt RT. 1989. Relationship between intercellular concentration of S-adenosylhomocysteine and inhibitors of vaccinia virus replication and inhibition of murine L929 cell growth. Antimicrob Agents Chemotherap 333:828-834.
13. Keller BT, Bochardt RT. 1986. Metabolism and mechanism of action of neplanocin A: A potential inhibitor of S-adenosyl homocysteine hycholase. In: Borchardt RT, Creveling CR, Ueland PM, eds. Biological methylation and drug design. Totawa, New Jersey: Humana Press, pp 385-396.
14. Keller BT, Borchardt RT. 1988. Inhibition of S-adenosylmethionine-dependent transmethylation as an approach to the development of antiviral agents. In: DeClercq E, Walker RT, eds. Antiviral drug development - A multidisciplinary approach. New York: Plenum Press, pp 123-138.
15. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
16. Liu S, Wnuk S, Robins MJ, Yuan CS, Borchardt RT. 1993. Adenosine 5′-carboxaldehyde: A potent inhibitor of S-adenosyl-L-homocysteine hydrolase. J Med Chem 36:883-887.
17. Liu S, Wolfe MS, Borchardt RT. 1992. Rational approach to the design of antiviral agents based on S-adenosylhomocysteine hydrolase as a molecular target. Antiviral Res 19:247-265.
18. Mas TM, Chen HH, Aisaka K, Lin LN, Brandts JF. 1995. Effects of C-terminal deletion of phosphoglycerate kinase. Biochemistry 34:7931-7940.
19. McCarthy JR, Jarvi ET, Metthew DP, Edwards ML, Prakash MJ, Bowling TL, Mehdi S, Sunkara PS, Bey P. 1989. 4′,5′-Unsaturated 5′-fluoroadenosine nucleosides: Potent mechanism-based inhibitors of S-adenosylhomocysteine hydrolase. J Am Chem Soc 111:1127-1128.
20. Mulkerrin MG, Cunningham BC. 1993. Spectral analysis of site-directed mutants of human growth hormone. In: Cleland JL, ed. Protein in vivo and vitro. Washington, DC: American Chemical Society, pp 240-253.
21. Ogawa H, Gomi T, Muecklar MM, Fujioka M, Backlund PS Jr, Aksamit RR, Unson CG, Cantoni GL. 1987. Amino acid sequence of S-adenosyl-L-homocysteine hydrolase from rat liver as derived from the cDNA sequence. Proc Natl Acad Sci USA 84:719-723.
22. Price NC, Johnson CM. 1990. Proteinases as probes of conformation of soluble proteins. In: Beynon RJ, Bond JS, eds. Proteolytic enzymes: A practical approach. New York: IRL Press, pp 163-180.
23. Ransohoff RM, Narayan P, Ayers DF, Rottman FM, Nilsen TW. 1987. Priming of influenza mRNA transcription is inhibited in CHO cells treated with the methylation inhibitor neplanicin A. Antiviral Res 7:317-327.
24. Robins MJ, Samano V, Zhang W, Balzarini J, DeClercq E, Borchardt RT, Lee Y, Yuan CS. 1992. Nucleic acid related compounds. 74. Synthesis and biological activity of 2′ (and 3′)-deoxy 2′ (and 3′)-methylene nucleoside analogs that function as mechanism-based inhibitors of S-adenosyl-L-homocysteine hydrolase and/or ribonucleotide reductase. J Med Chem 35:2283-2293.
25. Shortle D, Meeker AK, Freire E. 1988. Stability mutants of staphylococcal nuclease: Large compensating enthalpy-entropy changes for the reversible denaturation reaction. Biochemistry 27:4761-4768.
26. Turner MA, Dole K, Yuan CS, Hershfield MS, Borchardt RT, Howell PL. 1997. Crystallization and preliminary X-ray analysis of human placental S-adenosylhomocysteine hydrolase. Acta Crystallogr D53:339-341.
27. Wolfe MS, Borchardt RT. 1991. S-Adenosyl-L-homocysteine hydrolase as a target for antiviral chemotherapy. J Med Chem 34:1521-1530.
28. Yeh JC, Borchardt RT, Vedeni A. 1991. A molecular model of the active site of S-adenosylhomocysteine hydrolase. J Comput-Aided Mol Design 15:213-234.
29. Yuan CS, Ault-Riche DB, Borchardt RT. 1996. Chemical modification and site-directed mutagenesis of cysteine residues in human placental S-adenosylhomocysteine hydrolase. J Biol Chem 271:28009-28016.
30. 3H]8-azido-adenosine. J Biol Chem 270:16140-16146.
31. Yuan CS, Yeh JC, Squier TC, Rawitch A, Borchardt RT. 1993. Ligand-dependent intrinsic fluorescence changes of S-adenosylhomocysteine hydrolase: Implication about the mechanism of inhibitor induced inactivation. Biochemistry 32:10414-10422.
32. Zappacosta F, Pessi A, Bianchi E, Sara V, Sollazzo M, Tramontano A, Marino G, Pucci P. 1986. Probing the tertiary structure of proteins by limited proteolysis and mass spectroscopy: The case of minibody. Protein Sci 5:802-813.
33. Zhukovsky EA, Mulkerrin MG, Presta LG. 1994. Contribution to global protein stability of the N-capping box in human growth hormone. Biochemistry 33:9856-9864.